2021 Grant Recipient Shannon Oda, PhD
2021 Grantee: Shannon Oda, PhD
Seattle Children’s Research Institute, University of Washington
Research Project:
Developing Engineered Proteins to Enhance Adoptive Cell Therapy of PDA
Award: 2021 Pancreatic Cancer Action Network Career Development Award made possible by Linda E. Amuso in memory of Susan A. Lombardi
Award Period: July 1, 2021 – June 30, 2023
Amount: $200,000
Biographical Highlights
After receiving her undergraduate degree at Linfield College, Dr. Oda conducted research at a biotech company in Oregon, with a focus on treating diabetes in a mouse model. She completed her doctorate under the guidance of Raul Torres, PhD, at the University of Colorado Anschutz Medical Campus and National Jewish Health, where she described new immune-based pathways to control tumor progression in mice. Dr. Oda worked as a postdoctoral fellow and Research Associate in the lab of Philip Greenberg, MD, recipient of the 2016 PanCAN Translatio
1 of 39
A food delivery worker wearing a face mask carries orders during a heavy downpour in downtown Kuala Lumpur, Malaysia, Thursday, July 8, 2021. Malaysia starts further tightening movement curbs and imposes a curfew in most areas in its richest state Selangor and parts of Kuala Lumpur, where coronavirus cases remain high despite a national lockdown last month. Vincent Thian
A waiter wearing a face mask to protect against coronavirus serves customers at the Champs Elysees avenue in Paris, Monday, July 12, 2021. France s President Emmanuel Macron is hosting a top-level virus security meeting Monday morning and then giving a televised speech Monday evening, the kind of solemn speech he s given at each turning point in France s virus epidemic.
The Latest: US virus cases rising again, doubled in 3 weeks startribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from startribune.com Daily Mail and Mail on Sunday newspapers.
Mathematical modeling helped inform early statewide policies to reduce COVID-19 transmission
Colorado researchers have published new findings in
Emerging Infectious Diseases that take a first look at the use of SARS-CoV-2 mathematical modeling to inform early statewide policies enacted to reduce the spread of the Coronavirus pandemic in Colorado. Among other findings, the authors estimate that 97 percent of potential hospitalizations across the state in the early months of the pandemic were avoided as a result of social distancing and other transmission-reducing activities such as mask wearing and social isolation of symptomatic individuals.
The modeling team was led by faculty and researchers in the Colorado School of Public Health and involved experts from the University of Colorado Anschutz Medical Campus, University of Colorado Denver, University of Colorado Boulder, and Colorado State University.
Study: Opioid prescribing preferences, practices among surgical residents and faculty differ
Opioid prescribing preferences and practices among surgical residents and faculty differ, according to a new study published in the journal
Surgery.
The study, titled Evaluation of opioid prescribing preferences among surgical residents and faculty, was based on a survey of 56 residents and 57 faculty within the University of Colorado School of Medicine Department of Surgery. In the survey, participants were asked how many oxycodone tablets they would prescribe for 14 common surgical procedures.
Answers were compared between residents and faculty, as well as against the Opioid Prescribing Engagement Network (OPEN) guidelines and actual opioids prescribed (pulled from electronic medical records).